Common Contracts
4 similar Underwriting Agreement contracts by Jazz Pharmaceuticals PLC, Avago Technologies LTD, SMART Global Holdings, Inc.
3,000,000 Shares SMART Global Holdings, Inc. Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • July 13th, 2021 • SMART Global Holdings, Inc. • Semiconductors & related devices • New York
Certain shareholders of SMART Global Holdings, Inc., an exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Company”), named in Schedule II attached hereto (the “Selling Shareholders”) propose to sell to the underwriter listed in Schedule I hereto (the “Underwriter”) an aggregate of 3,000,000 ordinary shares (the “Shares”), par value $0.03 per share (the “Ordinary Shares”), in the capital of the Company. This agreement (this “Agreement”) is to confirm the agreement concerning the purchase of the Shares from the Selling Shareholders by the Underwriter.
JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • March 6th, 2013 • Jazz Pharmaceuticals PLC • Pharmaceutical preparations • New York
The certain shareholders of Jazz Pharmaceuticals Public Limited Company, a public limited company incorporated in Ireland (the “Company”) named in Schedule 2 (the “Selling Shareholders”) attached to this Agreement (this “Agreement”) propose to sell an aggregate of 5,375,000 shares (the “Shares”) of the Company’s ordinary shares, nominal value $0.0001 per share (the “Ordinary Shares”) to the underwriter named in Schedule 1 attached hereto (the “Underwriter”), for whom Barclays Capital Inc. is acting as Representative (the “Representative”). This Agreement is to confirm the agreement concerning the purchase of the Shares from the Selling Shareholders by the Underwriter.
AVAGO TECHNOLOGIES LIMITED Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • December 10th, 2012 • Avago Technologies LTD • Semiconductors & related devices • New York
Certain shareholders of Avago Technologies Limited, a company organized under the laws of the Republic of Singapore (the “Company”), named in Schedule 2 attached hereto (the “Selling Shareholders”), propose to sell an aggregate of 21,490,022 (the “Shares”) of the Company’s Ordinary Shares, no par value per share (the “Ordinary Shares”). This is to confirm the agreement concerning the purchase of the Shares from the Selling Shareholders by the underwriter (the “Underwriter”) named in Schedule 1 attached to this agreement (this “Agreement”).
JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • March 7th, 2012 • Jazz Pharmaceuticals PLC • Pharmaceutical preparations • New York
The certain shareholders of Jazz Pharmaceuticals Public Limited Company, a public limited company incorporated in Ireland (the “Company”) named in Schedule 2 (the “Selling Shareholders”) attached to this Agreement (this “Agreement”) propose to sell an aggregate of 7,883,366 shares (the “Shares”) of the Company’s ordinary shares, nominal value $0.0001 per share (the “Ordinary Shares”) to each of the underwriters named in Schedule 1 attached hereto (the “Underwriters”), for whom Barclays Capital Inc. and Citigroup Global Markets Inc. are acting as Representatives (the “Representatives”). This Agreement is to confirm the agreement concerning the purchase of the Shares from the Selling Shareholders by the Underwriters.
